Humanigen Inc (HGENQ)

[cowtown jay]

Novavax has almost the same OS that Humanigen has, (Shares Outstanding 118.79M) and they are now trading at a 52 week low. I would love to see a stock-for-stock business combination or partnership with them. Huge potential. Look at their 5 year chart.

https://ih.advfn.com/stock-market/NASDAQ/novavax-NVAX/chart/real-time

Even if they only used the lenz vaccine cocktail for immuno-compromised and elderly patients, and even if that only popped our Market Cap to $8B, that could still be a sustained annual revenue of $67 per share for Humanigen.

Yes, I have a recognized, long-standing, pro-bias opinion toward Novavax. But we developed our patent for a reason, and this is the ideal application for that patent.

"METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY
Publication number: 20230109208
Abstract: The present invention provides methods for treating a subject infected with 2019 coronavirus (SARS-CoV-2) comprising administering to the subject a therapeutically effective amount of a GM-CSF antagonist or a therapeutically effective amount of a GM-CSF antagonist and a second drug, including an anti-viral agent, an anti-SARS-CoV-2 vaccine, and serum containing human polyclonal antibodies to SARS-CoV-2.
Type: Application
Filed: March 8, 2021
Publication date: April 6, 2023
Applicant: HUMANIGEN, INC.
Inventors: Cameron DURRANT, Dale CHAPPELL

https://patents.justia.com/assignee/humanigen-inc